Overview
Mary Hubert is a Palliative Medicine provider in Louisville, Kentucky. Dr. Hubert is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Hubert is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 E Chestnut St, Fl 6, Louisville, KY 40202
234 E Gray St, Suite 154, Louisville, KY 40202
University Of Louisville Physicians Inc
Rohit Kumar is a Hematologist Oncology specialist and a Palliative Medicine provider in Louisville, Kentucky. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Adult Soft Tissue Sarcoma, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Prostate Cancer, and Thalamotomy. Dr. Kumar is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Hubert isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Hubert isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.